Literature DB >> 3036065

Procollagenase activator produced by rabbit uterine cervical fibroblasts.

M Ishibashi, A Ito, K Sakyo, Y Mori.   

Abstract

Culture medium from rabbit uterine cervical fibroblasts contained a procollagenase and a neutral proproteinase which acts as a procollagenase activator. These two proenzymes have been purified by a combination of ion-exchange, affinity and gel chromatographies. The purified neutral proproteinase showed Mr 60,000 with sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. This neutral proproteinase was activated by trypsin, 4-aminophenylmercuric acetate (APMA) and plasmin, and the active species of the proteinase had Mr 53,000 when activated by APMA; kallikrein and urokinase did not activate this proproteinase. The purified neutral proteinase was inhibited by EDTA, 1,10-phenanthroline and rabbit plasma, but not by serine proteinase inhibitors, suggesting that this proteinase is a metal-dependent proteinase. The purified enzyme could also degrade gelatin, casein, proteoglycan and type IV procollagen. The purified procollagenase had Mr 55,000 and was activated by trypsin, APMA and the active neutral proteinase. These activations were accompanied by decrease in Mr, and the activated species had an Mr which was approx. 10,000 less than that of the procollagenase. In particular, procollagenase activation with neutral proteinase depended on incubation time and proteolytic activity of proteinase. These results indicate that activation of procollagenase by the rabbit uterine neutral proteinase is related to limited proteolysis in the procollagenase molecule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036065      PMCID: PMC1147592          DOI: 10.1042/bj2410527

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Evidence for the presence of a complex of collagenase with alpha2-macroglobulin in human rheumatoid synovial fluid: a possible regulatory mechanism of collagenase activity in vivo.

Authors:  S Abe; Y Nagai
Journal:  J Biochem       Date:  1973-04       Impact factor: 3.387

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components.

Authors:  W A Galloway; G Murphy; J D Sandy; J Gavrilovic; T E Cawston; J J Reynolds
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

4.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

5.  Partial purification and characterization of gelatinase and metal dependent peptidase from rabbit uterus and their synergistic action on gelatin in vitro.

Authors:  K Sakyo; J Kobayashi; A Ito; Y Mori
Journal:  J Biochem       Date:  1983-12       Impact factor: 3.387

6.  Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase.

Authors:  L I Fessler; K G Duncan; J H Fessler; T Salo; K Tryggvason
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

7.  Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules.

Authors:  C L Mainardi; S N Dixit; A H Kang
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

8.  Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid.

Authors:  H Nagase; T E Cawston; M De Silva; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1982-03-18

9.  An alkaline metallo-proteinase in the human uterine cervix an changes in its activity by cervical ripening.

Authors:  A Ito; K Kitamura; S Hirakawa; Y Mori
Journal:  Biochim Biophys Acta       Date:  1981-10-13

10.  The gelatinolytic activity of rat uterus collagenase.

Authors:  H G Welgus; G A Grant; J C Sacchettini; W T Roswit; J J Jeffrey
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

View more
  7 in total

1.  Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.

Authors:  G Murphy; M I Cockett; P E Stephens; B J Smith; A J Docherty
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

2.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.

Authors:  C S HE; S M Wilhelm; A P Pentland; B L Marmer; G A Grant; A Z Eisen; G I Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  Myocardial matrix metalloproteinase(s): localization and activation.

Authors:  S C Tyagi; A Ratajska; K T Weber
Journal:  Mol Cell Biochem       Date:  1993-09-08       Impact factor: 3.396

4.  Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.

Authors:  Y Okada; N Takeuchi; K Tomita; I Nakanishi; H Nagase
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

5.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

Authors:  B L Gruber; M J Marchese; K Suzuki; L B Schwartz; Y Okada; H Nagase; N S Ramamurthy
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

Authors:  M Mohtai; R L Smith; D J Schurman; Y Tsuji; F M Torti; N I Hutchinson; W G Stetler-Stevenson; G I Goldberg
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts.

Authors:  A Ito; S Nakajima; Y Sasaguri; H Nagase; Y Mori
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.